Ten-year outcome of anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration

PURPOSE: The aim of this study was to report the 10-year visual outcome in eyes treated with anti-vascular endothelial growth factor (anti-VEGF) agents for neovascular age-related macular degeneration (nAMD) and to assess the impact of switching treatment as part of routine clinical care. METHODS: E...

Descripción completa

Detalles Bibliográficos
Autores principales: Upasani, Deepa, Dhingra, Narendra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544087/
https://www.ncbi.nlm.nih.gov/pubmed/34427220
http://dx.doi.org/10.4103/ijo.IJO_2868_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544087/
https://www.ncbi.nlm.nih.gov/pubmed/34427220
http://dx.doi.org/10.4103/ijo.IJO_2868_20

Ejemplares similares